Tag: Prescription Drugs

Mean glycated hemoglobin level at 26 weeks increased with placebo, decreased with dulaglutide among youth with BMI >85th percentile

At week 72, reduction in body weight greater with tirzepatide compared with placebo

Relative change from 2016 to 2019 varied from −52.0 percent in Mississippi to −6.9 percent in New Hampshire

Fewer renal complications seen with tirzepatide versus insulin glargine in adults with T2D and increased cardiovascular risk

Risk for metabolic or cardiovascular adverse events increased for men receiving abiraterone or enzalutamide for advanced disease

Addition of ibrutinib to chemoimmunotherapy prolongs progression-free survival in older patients with untreated mantle-cell lymphoma

At pandemic outset, significant decreases in buprenorphine prescription fills seen for Black, Hispanic patients, but not White patients

Compared with DPP-4 inhibitor use, SGLT2 inhibitor use not associated with higher risk for fractures, regardless of eGFR

Authors say this association may be relevant to psoriasis management with some antipsoriatic agents

Risks for ASD, intellectual disability may be increased with prenatal exposure to topiramate, valproate, certain duotherapies